How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
Level V
Where this comes from
- Record sourced from PubMed, PMID 19539891.
- Also identified by DOI 10.1016/j.ajog.2009.04.020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prognostic factors in early cervical cancer have been debated for many years and have been used as an indication for postradical hysterectomy radiation therapy. A recent Gynecologic Oncology Group protocol suggested that large lesions, deep invasion, or capillary-like space had better recurrence-free survival, but not overall survival, if postoperative radiation was given. When the published data were evaluated, the authors' conclusions were questioned. The choice of prognostic factors does not seem appropriate based on the data that were presented.
Medical subject headings
- Adenocarcinoma
- Carcinoma, Squamous Cell
- Uterine Cervical Neoplasms